Tamoxifen induced endometrial abnormalities: evaluation by saline infusion sonohysterography
- PMID: 9294952
Tamoxifen induced endometrial abnormalities: evaluation by saline infusion sonohysterography
Abstract
Patients receiving tamoxifen therapy for breast cancer are at an increased risk for endometrial hyperplasia, polyps, and adenocarcinoma. Therefore, any bleeding in the post-menopausal patient on tamoxifen warrants further investigation. Sonohysterography is a new technique for evaluating the uterine cavity and clarifying the location of endometrial and peri-endometrial processes. Differentiating subendometrial cyst formation from endometrial proliferation can save patients from further, invasive investigative diagnostic procedures.
Similar articles
-
Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium.J Ultrasound Med. 1995 Sep;14(9):685-8. doi: 10.7863/jum.1995.14.9.685. J Ultrasound Med. 1995. PMID: 7500435
-
The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.Gynecol Oncol. 2004 May;93(2):328-35. doi: 10.1016/j.ygyno.2004.01.032. Gynecol Oncol. 2004. PMID: 15099941
-
Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.Am J Obstet Gynecol. 1998 Jun;178(6):1145-50. doi: 10.1016/s0002-9378(98)70315-1. Am J Obstet Gynecol. 1998. PMID: 9662294
-
Tamoxifen and the uterus: an old drug tested by new modalities.Ultrasound Obstet Gynecol. 1996 May;7(5):374-8. doi: 10.1046/j.1469-0705.1996.07050374.x. Ultrasound Obstet Gynecol. 1996. PMID: 8774108 Review.
-
[Benign endometrial lesions induced by tamoxifen].J Gynecol Obstet Biol Reprod (Paris). 1999 Sep;28(5):420-4. J Gynecol Obstet Biol Reprod (Paris). 1999. PMID: 10566160 Review. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical